Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
SARS-CoV-2의 스파이크 단백질 돌연변이가 COVID-19 백신의 실패로 이어질까요?
Review
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
Affect
B.1.1.7
B.1.351
Brazil
causative agent
concerning
coronavirus disease
Coronavirus disease 2019
Coronavirus-2
COVID-19
COVID-19 vaccine
COVID-19 vaccines
E484K
Effect
explain
failure
K417N
Lineage
lineage B.1
Lineage B.1.1.7
Mutation
N501Y
N501Y mutation
P.1
Protein
Research
respiratory
S protein
S protein variant
SARS-CoV-2
SARS-CoV-2 spike
SARS-CoV-2 variant
SARS-CoV-2 variants
Severe acute respiratory syndrome
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus-2
South Africa
spike
Spike protein
Spread
strain
target
the S protein
the SARS-CoV-2
the Spike
Transmissibility
Transmission
United Kingdom
Vaccine
variant
Viral
viral fitness
virus
Wuhan
Wuhan, China
[DOI] 10.3346/jkms.2021.36.e124 PMC 바로가기 [Article Type] Review
[DOI] 10.3346/jkms.2021.36.e124 PMC 바로가기 [Article Type] Review